Promote cheaper, domestic-made COVID medicines: Parliamentary Panel to Govt officials

During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines be capped, they said.

Published On 2020-07-17 08:50 GMT   |   Update On 2020-07-17 08:50 GMT

New Delhi: A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and prices of expensive medicines pushed by pharma companies, sources said.During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines...

Login or Register to read the full article

New Delhi: A parliamentary panel told senior government officials on Wednesday to promote cheaper and easily available domestic-made medicines for COVID-19, and check recommendation and prices of expensive medicines pushed by pharma companies, sources said.

During a meeting of the Parliamentary Standing Committee on Home Affairs, members demanded that the maximum price of COVID-19 medicines be capped, they said.

Home Secretary Ajay Bhalla, Joint Secretary in Health Ministry Lav Agarwal and other officials were present in the meeting chaired by Congress leader Anand Sharma.

Cutting across party lines, the committee members questioned why expensive medicines were often being recommended for COVID-19 treatment, sources in the panel said.

The committee members expressed concern over black marketing of medicines.

Naming three cheaper and easily available medicines, the committee members questioned why are they not being promoted despite being equally effective.

Read also: Govt likely to issue unique QR Coding for all medicine packs


Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News